ADVERTISEMENT
CURRENT ISSUE
APRIL 2014
KINDLE EDITION


SLEEP Seeking New Editor

The APSS is seeking qualified candidates for editor-in-chief of SLEEP



SEARCH JOURNAL ARCHIVES


SEARCH PUBMED


MANUSCRIPT SUBMISSIONS


SUBSCRIBE TO SLEEP

CONTINUING MEDICAL EDUCATION


ADVERTISE WITH US


ABOUT SLEEP

ABSTRACT SUPPLEMENTS


ACCEPTED PAPERS
Bookmark and Share         RSS Feed

VOLUME 36, ISSUE 01

OSA ASSOCIATED WITH CHEMOREFLEX SENSITIVITY IN METABOLIC SYNDROME
Obstructive Sleep Apnea is Associated with Increased Chemoreflex Sensitivity in Patients with Metabolic Syndrome

http://dx.doi.org/10.5665/sleep.2298

Ivani C. Trombetta, PhD1; Cristiane Maki-Nunes, PhD1; Edgar Toschi-Dias, BS1; Maria-Janieire N. N. Alves, MD, PhD1; Maria Urbana P. B. Rondon, PhD1,2; Felipe X. Cepeda, BS1; Luciano F. Drager, MD, PhD1; Ana Maria F. W. Braga, MD, PhD1; Geraldo Lorenzi-Filho, MD, PhD1; Carlos E. Negrao, PhD1,2

1Heart Institute (InCor), University of S̃ao Paulo Medical School, S̃ao Paulo, Brazil; 2School of Physical Education and Sports, University of S̃ao Paulo, S̃ao Paulo, Brazil



  Expand  Table of Contents    
Text size:  

Study Objectives:

Obstructive sleep apnea (OSA) is often observed in patients with metabolic syndrome (MetS). In addition, the association of MetS and OSA substantially increases sympathetic nerve activity. However, the mechanisms involved in sympathetic hyperactivation in patients with MetS + OSA remain to be clarified. We tested the hypothesis that chemoreflex sensitivity is heightened in patients with MetS and OSA.

Design:

Prospective clinical study.

Participants:

Forty-six patients in whom MetS was newly diagnosed (ATP-III) were allocated into: (1) MetS + OSA (n = 24, 48 ± 1.8 yr); and (2) MetS – OSA (n = 22, 44 ± 1.7 yr). Eleven normal control subjects were also studied (C, 47 ± 2.3 yr).

Measurements:

OSA was defined as an apnea-hypopnea index ≥ 15 events/hr (polysomnography). Muscle sympathetic nerve activity (MSNA) was measured by microneurography technique. Peripheral chemoreflex sensitivity was assessed by inhalation of 10% oxygen and 90% nitrogen (carbon dioxide titrated), and central chemoreflex sensitivity by 7% carbon dioxide and 93% oxygen.

Results:

Physical characteristics and MetS measures were similar between MetS + OSA and MetS – OSA. MSNA was higher in MetS + OSA patients compared with MetS – OSA and C (33 ± 1.3 versus 28 ± 1.2 and 18 ± 2.2 bursts/min, P < 0.05). Isocapnic hypoxia caused a greater increase in MSNA in MetS + OSA than MetS – OSA and C (P = 0.03). MSNA in response to hyperoxic hypercapnia was greater in MetS + OSA compared with C (P = 0.005). Further analysis showed a significant association between baseline MSNA and peripheral (P < 0.01) and central (P < 0.01) chemoreflex sensitivity. Min ventilation in response to hyperoxic hypercapnia was greater in MetS + OSA compared with C (P = 0.001).

Conclusion:

OSA increases sympathetic peripheral and central chemoreflex response in patients with MetS, which seems to explain, at least in part, the increase in sympathetic nerve activity in these patients. In addition, OSA increases ventilatory central chemoreflex response in patients with MetS.

Citation:

Trombetta IC; Maki-Nunes C; Toschi-Dias E; Alves MJNN; Rondon MUPB; Cepeda FX; Drager LF; Braga AMFW; Lorenzi-Filho G; Negrao CE. Obstructive sleep apnea is associated with increased chemoreflex sensitivity in patients with metabolic syndrome. SLEEP 2013;36(1):41-49.

Expand  Table of Contents
ADVERTISEMENT
Classifieds View SLEEP 2011 Poster Presentations Online